The US Food and Drug Administration has permitted a brand new indication for the immunotherapy drug atezolizumab (Tecentriq) — the adjuvant medication following resection and platinum-based solely…
The US Food and Drug Administration has permitted a brand new indication for the immunotherapy drug atezolizumab (Tecentriq) — the adjuvant medication following resection and platinum-based solely…